Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001385508-19-000054)

Filing Details

Accession Number:: 0001385508-19-000054
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-06-04 16:21:20
Reporting Period:: 2019-06-03

Accepted Time:: 2019-06-04 16:21:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1385508	Opiant Pharmaceuticals Inc.	OPNT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1358116	Phil Skolnick	C/O Opiant Pharmaceuticals, Inc. 201 Santa Monica Blvd., Suite 500 Santa Monica CA 90401	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-06-03	10,000	$9.00	10,000	No	4	M	Direct
Common Stock	Disposition	2019-06-03	8,414	$11.72	1,586	No	4	S	Direct
Common Stock	Disposition	2019-06-04	1,586	$11.63	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2019-06-03	10,000	$0.00	10,000	$9.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
110,000	2018-08-06	2027-02-06	No	4	M	Direct

Footnotes

The option was exercised pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.